Beijing, China

Zewang Feng

This inventor holds 21 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 10 EPO patents, primarily in Polyethylene Glycol Conjugates. Top assignees: Jenkem Technologyco., Ltd.. (Tianjin), Jenkem Technology Co., Ltd. (Beijing), Beijing Tide Pharmaceutical Co., Ltd.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zewang Feng. Retrieved from https://idiyas.com/inventor/zewang-feng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 95.2

 

 

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Beijing, CN (2015 - 2023)
  • Tianjin, CN (2017 - 2024)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Polyethylene Glycol
Drug Conjugate
Local Anesthetic
Analgesia
Pharmaceutical Composition
Multi-Drug Loading
Rho-Associated Protein Kinase
Inhibitory Activity
Preparation Method
Solid Form
Click Chemistry
Ligand-Drug Conjugate
21 patents (USPTO):Explore Patents

Title: Innovations by Inventor Zewang Feng

Introduction

Zewang Feng is a prominent inventor based in Beijing, China, known for his exceptional contributions to the field of chemical engineering and drug delivery systems. With a remarkable portfolio of 18 patents, his innovative work focuses on developing linker compounds and polyethylene glycol derivatives to enhance drug modification and delivery efficiency.

Latest Patents

Zewang Feng's latest patents highlight significant advancements in the pharmaceutical industry. One of his key inventions is the creation of a linker compound, polyethylene glycol-linker conjugate and its derivatives. This technology allows for the modification of drugs in a straightforward manner with a high reaction yield. The resulting modified drugs exhibit sustained and controlled release properties, which are particularly beneficial for targeting lesions, such as cancer sites, thereby enhancing bioavailability and improving patient compliance.

Another notable patent is the multi-arm multi-claw polyethylene glycol derivative designed for click chemistry reactions. This innovation, represented by a general formula, provides a versatile structure for drug development, further showcasing Zewang's expertise in creating vital pharmaceutical technologies.

Career Highlights

Throughout his career, Zewang Feng has made significant strides in the realm of drug delivery and optimization. His tenure at Jenkem Technology Co., Ltd. has been instrumental in driving his research forward. He has continuously contributed to the growth of innovative solutions in the pharmaceutical sector, thereby establishing himself as a key player in the industry.

Collaborations

Zewang Feng has worked closely with talented colleagues such as Xuan Zhao and Jinliang Wang. These collaborations have fostered an environment of shared expertise and innovation, culminating in groundbreaking advancements in the field of drug modification and delivery systems.

Conclusion

In conclusion, Zewang Feng stands out as an influential inventor with a wealth of knowledge and expertise in chemical engineering. His patents reflect a commitment to innovation that addresses critical challenges in medicine, particularly in enhancing drug efficacy and patient experience. As he continues to develop his ideas, the impact of his inventions is sure to resonate within the pharmaceutical industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…